Mutations leading to the activation of BRAF (the B isoform of RAF) were detected in 27-70% of melanoma, 36-53% of papillary thyroid cancer, 5-22% of colorectal cancer, and 30% of ovarian cancer [90]. This evidence concerns the gene BRAF and melanoma.